![]() |
Page History
...
- Debbie to work with Ralph to write invitation for Jaime Modiano
- Gina to speak with Debbie to arrange a meeting with Gerry to discuss data submission (Toby, Debbie, Phil)
- Revisit new steering committee members in September (loop Connie into this discussion)
Agenda
Item | Who | Talking Points |
---|
Debbie Knapp
We asked FidoCure if they had data on glioma, osterosarcoma, bladder cancer, mucosal and acral melanoma, and mast cell tumor.
- Gerry Post replied “We do have data on osteosarcoma, mast cell tumors and some acral melanomas. As for gliomas and urothelial carcinomas, biopsies are much less common so we have less data.” Although he does not specify, I would think they would have lots of data on mucosal oral melanoma too.
- If we want to pursue this further, I think Gerry would like a more specific request that he will then take to his board.
Discussion with FidoCure | Dr. Gerald Post, Chief Medical Officer at FidoCure Ben Toussant, Vice President of Operations at FidoCure |
|
New ICDC Subcommittee: Cross-Species Mapping Committee (CSMC) Purpose: Facilitation of human-canine comparative data analysis from the ICDC and other nodes in the CRDC using interoperability components such as Cancer Data Aggregator and aligning with data standards | All |
|
|
|
| ||
New ICDC Subcommittee: Longitudinal Data Acquisition and Use Committee (LDAUC) Purpose: Formulate scientific questions and use cases that can be used to interrogate longitudinal datasets that would justify the ingestion of such data into the ICDC.. | All |
|
DGAB Updates | Recently Released ICDC Studies in Active Submission
|
New ICDC Bioinformatics Tutorial Website |
| ||
ICDC Biospecimen Data |
|
Upcoming Steering Committee Meeting | Ralph Parchment |
|
|
Minutes (Not Verbatim)
TH - Golden Retriever Lifetime study has contacted us with biospecimen data, they would like a discussion. Could we have a page within the application to redirect users to biospecimen data? We could let them know about the potential for displaying URLs for their biospecimen data. We could organize this data by type (ie. plasma, mast cell, circulating tumor cells, etc.), we could provide contact information at the consortium level).
...
8. Develop biomarkers of response and resistance in humans by analyzing the responses and genomic signatures in dogs.
Action items
- Gina to speak with Debbie to arrange a meeting with Gerry to discuss data submission (Toby, Debbie, Phil)
- Toby to invite Greg from CCDI to the next Executive Team Meeting in January
- Toby to look across the NCI directory to find person that has a combination of canine and pediatric oncology background